Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 04 2024
0mins
Source: Globenewswire
Grace Therapeutics Participation: Grace Therapeutics, Inc. will participate in the ASHP mid-year clinical meeting from December 8–12, 2024, to discuss their novel injectable formulation GTx-104 for treating aneurysmal subarachnoid hemorrhage (aSAH) and its potential benefits over current treatments.
KOL Event Insights: A recent virtual key opinion leader event highlighted the significant unmet medical needs in aSAH treatment, emphasizing the advantages of GTx-104's intravenous delivery method, which could improve patient outcomes and reduce complications associated with traditional administration methods.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
